STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells
Uri Rozovski(Rabin Medical Center), Zeev Estrov(The University of Texas MD Anderson Cancer Center)
Cited by 11
Related Papers
Ibrutinib and Venetoclax for First-Line Treatment of CLL
|New England Journal of Medicine|2019|502
Phase 1/2 study of the combination of 5-aza-2′-deoxycytidine with valproic acid in patients with leukemia
|Blood|2006|468
10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial
|The Lancet Haematology|2020|330